Embolotherapy Market

Embolotherapy Market is valued at USD 3268.1 Million in 2021 and is expected to reach USD 5568.4 Million by 2028 with a CAGR of 7.91% over the forecast period.

An increasing number of target patient populations, rising preference for minimally invasive procedures, technological advancements in embolotherapy devices, and favorable reimbursement policies are major factors driving the market growth.

Scope of Global Embolotherapy Market Report:-

Embolotherapy is a type of endovascular treatment that aims to block abnormal blood vessels in order to control bleeding, close fistulae or arteriovenous malformations, devascularise organs, reduce tumors and much more. To achieve blocking, embolotherapy performs minimally-invasive methods and several embolic agents, such as gelfoam, coils, balloons and angiographic catheters to reach exact and significant results. The embolic agents used can be either temporary or permanent and are determined according to the clinical application, and thus can differ greatly from case to case. Embolotherapies have become mainstay of interventional radiology practice. In order to achieve embolotherapy properly, IRs must be qualified, up-to-date on the modern data, aware with fundamental pathologies and well-informed on how other specialties can also contribute to patient treatment.

Global embolotherapy market report is segmented on the basis of product, disease indication, procedure, end-user and region & country level. Based on product, global embolotherapy market is classified into embolic agents, microspheres, embolic coils, liquid embolic agents, embolic plug systems, detachable balloons, support devices, microcatheters and guidewires. Based on disease indication, global embolotherapy market is classified into cancer, liver cancer, kidney cancer, other cancers, peripheral vascular diseases, neurological diseases, cerebral aneurysm, cerebral arteriovenous malformations and fistulas, gastrointestinal disorders, and urological and nephrological disorders. Based on procedure, the market is classified into transcatheter arterial embolization, transcatheter arterial radio embolization/selective internal radiation therapy, and transarterial chemoembolization. Based on end-user, global embolotherapy market is classified into hospitals and clinics, ambulatory surgical centers and others.

The regions covered in this Global Embolotherapy Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Embolotherapy is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Global Embolotherapy Market Key Players:-

major players in the Embolotherapy market include,

• Boston Scientific Corporation
• Merit Medical Systems
• Terumo Corporation
• Medtronic plc
• Johnson & Johnson
• Stryker Corporation
• BTG plc
• Penumbra, Inc
• Cook Medical
• Abbott Laboratories
• Acandis GmbH
• BALT Extrusion
• Sirtex Medical Limited
• Kaneka Corporation
• Meril Life Sciences Pvt. Ltd.

 

Global Embolotherapy Market Segmentation:-

By Product: -

• Embolic agents
• Microspheres
• Embolic coils (Detachable Coils, Pushable Coils)
• Liquid Embolic Agents
• Embolic Plug Systems
• Detachable Balloons
• Support Devices
• Microcatheters
• Guidewires

By Disease Indication:-

• Cancer
• Liver Cancer
• Kidney Cancer
• Other Cancers
• Peripheral Vascular Diseases
• Neurological Diseases
• Cerebral Aneurysm
• Cerebral Arteriovenous Malformations and Fistulas
• Gastrointestinal Disorders
• Urological
• Nephrological Disorders

By Procedure:-

• Transcatheter Arterial Embolization,
• Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
• Transarterial Chemoembolization

By End-User:-

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Other

Market Dynamics–

Rising incidences of peripheral vascular diseases, liver cancer, and strokes, coupled with a rising preference for minimally invasive procedures are the major factors driving the market growth. In addition, increasing investments and technological advancements in this field are also supplementing the market growth. According to the American Cancer Society, liver cancer is a leading cause of cancer deaths worldwide, accounting for more than 700,000 deaths each year. Also, according to the World Health Organization, 15 million people suffer stroke worldwide each year. Out of these, 5 million die, and an additional 5 million are permanently disabled. However, lack of sufficient evidence & unfavorable regulatory scenario may restrain the growth of the market. Moreover, increasing applications of embolization devices will offer lucrative opportunities for the further growth of the market.

Regional Analysis–

North America is expected to account for the largest market share of the global embolotherapy market during the forecast period. The growing geriatric population, increasing number of ambulatory surgery center (ASCs), and growing preference for minimally invasive surgeries have resulted in the increasing adoption of embolotherapy procedures in this region. According to U.S. department of health and human services, Ambulatory surgery proved to be popular among both physicians and patients and the number of Medicare-certified ASCs increased steadily, from 239 in 1983 to 5,316 in 2010.

Asia Pacific market is expected to grow at the highest CAGR during the forecast period owing to the large patient population of target diseases, and presence of key market players in the region to grab uplifting opportunities offered by these countries are the key factors supporting the market growth in this region.

Report Analysis	Details
Historical data	2015 - 2020
Forecast Period	2021 - 2028
Market Size in 2021:	USD 3268.1 Million
Base year considered	2020
Forecast Period CAGR %:	7.91%
Market Size Expected in 2028:	USD 5568.4 Million
Tables, Charts & Figures:	175
Pages	200
Embolotherapy Companies	Boston Scientific Corporation, Merit Medical Systems, Terumo Corporation, Medtronic plc, Johnson & Johnson, Stryker Corporation, BTG plc, Penumbra, Inc., Cook Medical, Abbott Laboratories, Acandis GmbH, BALT Extrusion, Sirtex Medical Limited, Kaneka Corporation, Meril Life Sciences Pvt. Ltd. and others.
Segments Covered	By Product, By Disease Indication, By Procedure, By End-User
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits for Embolotherapy Market Report–

• Global Embolotherapy Market report covers in-depth historical and forecast analysis.
• Global Embolotherapy Market research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country levels.
• Global Embolotherapy Market report helps to identify opportunities in the marketplace.
• Global Embolotherapy Market report covers an extensive analysis of emerging trends and competitive landscape.

On Special Requirements Embolotherapy Market Report is also available for the below Regions and Country:

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA